ECOR1 CAPITAL, LLC – Crinetics Pharmaceuticals, Inc. Transaction History
ECOR1 CAPITAL, LLC portfolio value:
$26.12M
portfolio value
ECOR1 CAPITAL, LLC quarter portfolio value change:
+5.31%
quarter
Crinetics Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.31M | $19.64 | 1.33M | |
| Q2 2022 | share | Increase | +68.34% | 540.05K shares | 7.46M | $18.65 | 1.33M |
| Q1 2022 | share | Increase | +33.90% | 200.04K shares | 578K | $21.95 | 790.20K |
| Q4 2021 | share | Increase | 0.00% | 590.16K shares | 16.76M | $28.03 | 590.16K |
| Q3 2020 | share | Decrease | -100.00% | -859.80K shares | -15.06M | $15.67 | 0 |
| Q2 2020 | share | Increase | +145.66% | 509.80K shares | 9.91M | $17.52 | 859.80K |
| Q1 2020 | share | Increase | 0.00% | 350K shares | 5.14M | $14.7 | 350K |